MedPath

Fosfomycin Tromethamine

Granules for Oral Solution Rx only

Approved
Approval ID

ca668546-c8ba-af0a-e053-2995a90a2300

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 3, 2023

Manufacturers
FDA

Zambon USA, Ltd

DUNS: 118086168

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fosfomycin Tromethamine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code82036-4274
Application NumberNDA050717
Product Classification
M
Marketing Category
C73605
G
Generic Name
Fosfomycin Tromethamine
Product Specifications
Route of AdministrationORAL
Effective DateOctober 3, 2023
FDA Product Classification

INGREDIENTS (5)

ORANGEInactive
Code: 5EVU04N5QU
Classification: IACT
SACCHARINInactive
Code: FST467XS7D
Classification: IACT
FOSFOMYCIN TROMETHAMINEActive
Quantity: 3 g in 1 1
Code: 7FXW6U30GY
Classification: ACTIM
TANGERINEInactive
Code: KH3E3096OO
Classification: IACT
SUCROSEInactive
Code: C151H8M554
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Fosfomycin Tromethamine - FDA Drug Approval Details